Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis
{{output}}
Metabolic syndrome (MetS) is considered to be an adverse effect of long-term treatment with atypical antipsychotics, particularly clozapine. There is strong evidence that the activation of inflammatory pathways interferes with normal metabolism and contributes... ...